The Impact of Activated Phosphoinositide 3-Kinase δ Syndrome (APDS) on Health-Related Quality of Life (HRQoL): Elicitation of Health State Utility Values Through Time Trade-Off (TTO) and EQ-5D
This is the first study to indirectly elicit utility values in APDS through valuation by the general population and clinical experts. This expands on the current literature for APDS by providing an overview of how HRQoL declines with disease progression and increasing number of manifestations.
Authors
- Ashley Enstone
- Robin Wyn
- Joanne B Tutein Nolthenius (ORCID: https://orcid.org/0009-0004-9491-0845)
- John Whalen
- Annabel Griffiths
- Olivia Dodd
Institutions
- Adelphi Group (United Kingdom) (GB)
- Pharming Group (Netherlands) (NL)
- Costello Medical Consulting (United Kingdom) (GB)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1007/s12325-025-03252-1
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00